Shaperon Inc

378800

Company Profile

  • Business description

    Shaperon Inc is a developer of innovative inflammasome inhibitors and nanobody therapeutics intended to develop novel treatments for various chronic inflammatory diseases, including atopic dermatitis, systemic inflammatory response syndrome, neuroinflammatory diseases, and chronic inflammation. It offers a range of drug candidates, including a gel-type atopic dermatitis drug for use in the treatment of systemic inflammatory response syndrome, neuroinflammatory diseases and for treating chronic inflammation. The company also provides immunotherapeutic products and a single-domain neutralizing antibody, enabling clients to improve patient’s quality of life by developing safe and efficacious drugs and immunotherapies.

  • Contact

    Gangnam Ace Tower G9
    Suie 218 & 606, 174-10 Jagok-ro, Gangnam-gu
    Seoul06373
    KOR

    T: +82 260838315

    http://www.shaperon.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    51

Stocks News & Analysis

stocks

Is this ASX share a long-term buy?

Current operating conditions are challenging but over the long-term prospects are better.
stocks

Why Guzman and Reece's share reversals have a lot in common

Investors must weigh exciting growth stories against competitive dynamics and the price they are being asked to pay.
stocks

Going into earnings, is Nvidia stock a buy, a sell, or fairly valued?

Watching the data centre business and the debate around it, here’s what we think of Nvidia stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,477.3020.70-0.24%
CAC 408,137.2686.191.07%
DAX 4022,732.24321.971.44%
Dow JONES (US)43,758.96137.800.32%
FTSE 1008,722.0353.360.62%
HKSE23,787.93753.913.27%
NASDAQ19,196.80170.410.90%
Nikkei 22538,142.3795.42-0.25%
NZX 50 Index12,452.46145.191.18%
S&P 5005,991.4536.200.61%
S&P/ASX 2008,240.7011.20-0.14%
SSE Composite Index3,380.2134.171.02%

Market Movers